More than 75 ~ of a random sample of adult human sera exhibited moderate to high murine pneumonia virus (PVM)-neutralizing activity. There was no correlation between PVM-neutralizing activity and respiratory syncytial virus or parainfluenza type 3 virus-neutralizing activities of the same sera. In children the proportion of sera with moderate to high titres increased with age, indicating early exposure to infection. Seroconversion (i.e. > fourfold increase in titre) was observed in four of 108 paired samples of previously undiagnosed respiratory infections. These observations suggest that the human population is frequently exposed to infection with PVM or an antigenically related virus.
INTRODUCTION
Murine pneumonia virus (PVM) and respiratory syncytial (RS) virus are the sole members of the genus Pneumovirus of the family Paramyxoviridae. Human RS virus is the principal cause of respiratory illness in infancy and is regularly isolated during annual epidemics. Bovine RS virus is considered to be a significant cause of respiratory disease in cattle and is frequently isolated from affected animals. The human and bovine RS viruses are antigenically very similar. Although RS virus antibodies have been detected in several other species of domestic, laboratory and wild animals (Lundgren et al., 1969; Pringle & Cross, 1978; Richardson-Wyatt et al., 1981 ; C. R. Pringle, unpublished data) , no RS-related viruses have been isolated from these animals. PVM, which is antigenically distinct from the RS viruses, is associated with latent or inapparent infection of mice (Horsfall & Hahn, 1939 , 1940 and is prevalent in most colonies of laboratory mice (Parker et al., 1966; Gannon & Carthew, 1980) . Serologically related viruses have been isolated from Syrian hamsters, cotton rats and rabbits (Eaton & van Herick, 1944; Horsfall & Curnen, 1946) . PVM-neutralizing activity has been detected in several other species (Horsfall & Hahn, 1940; Horsfall & Curnen, 1946) , but no PVM-like viruses have been isolated. In the 1940s, Horsfall and colleagues reported serological evidence of PVM infection in a minority of the human population, and in the search for causative agents responsible for primary atypical pneumonia recovered a number of agents from patients which induced PVMneutralizing antibodies in experimental animals (Horsfall et al., 1943) . The human agents were considered to be viruses antigenically related to PVM, but the data are difficult to interpret now since these agents could only be monitored by their ability to induce PVM-neutralizing antibodies in animal hosts known to harbour PVM.
Paget's disease of bone is a common chronic disorder of bone metabolism of unknown aetiology affecting the middle aged and elderly. Certain features of the disease suggest that it is the result of slow progressive virus infection (Rebel et al., 1977; Singer, 1980 (Mills et al., 1981 (Mills et al., , 1982 in the osteoclasts of affected tissue. Basl~ et al. (1986) have reported in addition detection of measles virus RNA sequences in affected tissue by in situ hybridization using a nucleocapsid-specific cDNA probe. The significance of these findings remains to be established. In the course of surveying patients with Paget's disease of bone for the presence of anti-paramyxovirus antibodies, it became apparent that the sera of the majority of patients in both the affected and control groups possessed PVM-neutralizing activity. Furthermore, as described below, a more marked association between high virus-neutralizing titres and confirmed Paget's disease of bone was observed with PVM, than was observed previously in screening for PI3 virus and RS virus antibodies (Pringle et al., 1985) .
Because of the unexpectedly high frequency of PVM-neutralizing activity in the sera of the bone clinic patients, the survey was extended to provide an estimate of the prevalence of PVMneutralizing antibody in the general population. The results suggest that exposure to infection by PVM, or an as yet uncharacterized serologically related virus, is widespread and frequent, and that infection occurs early in life and may be accompanied occasionally by respiratory illness.
METHODS
Virus. PVM strain 15 was obtained from the American Type Culture Collection and cloned by three sequential isolations from single plaques on BHK-21 cell monolayers (Cash et al., 1979) .
Cells. The BS-C-I line of African green monkey kidney cells was used for assay of PVM infectivity. Infected monolayers were incubated for 7 days at 37 °C under Eagle's MEM (Glasgow modification) with 1 ~ foetal calf serum (Flow Laboratories) and 0.9~ agar. The small deeply stained foci were counted after fixing with 1 glutaraldehyde and staining with crystal violet.
Standard neutralization test. PI3 virus-and RS virus-neutralizing activities were assayed essentially as described by Pringle & Cross (1978) and Pringle et al. (1985) . In the case of PVM, approximately 4 × 102 p.f.u, were mixed with an equal volume of twofold dilutions of the test serum. The dilution fluid was Eagle's MEM with 1 ~ foetal calf serum. The test sera were pretreated for 30 min at 56 °C to destroy non-specific inhibitors. The virus-serum mixtures were held at 4 °C for 18 h approximately and the residual infectivity was assayed by titration on BS-C-1 monolayers. The dilution of serum producing a 50~ reduction of infectivity was determined graphically and the titre of the serum is expressed as the reciprocal of this value. All determinations were carried out in duplicate. Up to 200 foci could be counted on a 35 mm Petri dish before loss of accuracy occurred due to overlap.
Abbreviated neutralization test.
For speed and economy an abbreviated neutralization test was employed as described in the text. Two dilutions only were used in place of the twofold dilution series of the standard test. The abbreviated test did not give a precise endpoint but was sufficient to allow reproducible classification of sera into low (< 40), intermediate (> 40 but < 320) and high (> 320) activity classes.
Serum samples. The serum samples taken from patients attending the Bone Disease Clinic at the Glasgow Western Infirmary between November 1981 and November 1982 have been described previously (Pringle et al., 1985) . Thirty-six samples were obtained from patients with Paget's disease and 137 from patients with other bone conditions. The mean age of the patients in the Paget's group was 67 years for men and 71 years for women, and 59 years for men and 62 years for women in the non-Paget's group.
The following series of samples were obtained from the Virology Department of the John Radcliffe Hospital: 126 samples from young adult women collected during screening for rubella virus antibody, 198 age-grouped samples from patients attending the John Radcliffe Hospital for various reasons, and 108 paired acute and convalescent serum samples from patients with respiratory illness of undetermined aetiology.
RESULTS

PVM-neutralizing activity in the sera of patients with Paget's disease of bone
A collection of serum samples obtained from 173 patients attending the Bone Disease Clinic of the Western Infirmary, Glasgow from November 1981 to November 1982 was screened for RS virus-and PI3 virus-neutralizing activities to investigate further the possible association of Paget's disease of bone with paramyxovirus infection (Basl6 et al., 1979 (Basl6 et al., , 1985 Howatson & Fournier, 1982; Mills et al., 1984; Pringle et al., 1985; Rebel et al., 1980; Singer, 1980; Singer & Mills, 1977 , 1983 Paget's disease of bone and 137 sera from patients with other conditions, have now been screened for PVM-neutralizing activity using the standard neutralization test. The results are shown in Fig. 1 . In contrast to the results obtained previously for RS virus-and PI3 virusneutralizing activities, there was a marked tendency for Paget's disease patients to have higher PVM-neutralizing titres in their sera than other patients. The data which are plotted as a histogram in Fig. 1 represent the entire collection of sera, but a similar result was obtained using a subset of age-and sex-matched sera (not shown); therefore, the lack of age-and sex-matching did not appear to bias the result. between these three activities, and that the anti-PVM activities appeared to fall into two distinct groups, i.e. those in the range < 40 to 80, and those in the range 320 to > 1280. There was also no relationship between the PVM-, PI3 virus-and RS virus-neutralizing activities of the individual sera of normal adults (data not shown). The PVM-neutralizing activity was presumed to be antibody-mediated because in five sera chosen at random it was depleted by adsorption with Staphylococcus aureus, Cowan I strain.
These sera were also able to precipitate the virus nucleocapsid protein from PVM-infected cells, and not the RS virus nucleocapsid protein from RS virus-infected cells, which is consistent with the presence of a specific immunoglobulin (data not shown).
PVM-neutralizing activity in the sera of young adults
Since the greatest proportion of anti-PVM titres were in the high (> 1280) titre range, it was decided to carry out a more extensive survey of the prevalence of anti-PVM neutralizing activity in the general population. An abbreviated neutralization test was devised to carry out this survey quickly and economically, taking account of the precision of the plaque assay for PVM on BS-C-1 monolayers which permitted accurate counting of up to 100 foci per well of a 12-well Costar plate. This test involved use of two dilutions 0/40 and 1/320) of the test serum and a 1/40 dilution of a negative control. The 50% plaque reduction titres were determined by graphical extrapolation from plaque counts on duplicate plates. The titres have been grouped into three broad categories for ease of presentation: i.e. low titres of 40 or less, moderate titres of greater than 40 and less than 320, and high titres of 320 and above.
This abbreviated assay proved to be convenient, economical and accurate in distinguishing sera into low, moderate and high activity categories. An estimate of the neutralization titres of a pair of serum samples could be obtained on a single 12-well Costar plate. The results in Tables 1  to 3 were obtained by this means.
Samples from young adult women collected in the course of screening for rubella virus infection in the Oxford area were examined to counterbalance the data in Fig. 1 obtained predominantly from elderly patients residing in the west of Scotland. The data in Table 1 indicate that moderate to high levels of PVM neutralizing activity were frequent in this group of 20 Recurrent URTI, 320 > 1280 depression sera also, and that at least 90~ of this population had experienced PVM infection by early adulthood. The prevalence of anti-PVM activity in the sera of this population was similar to that observed in the bone disease clinic patients in Glasgow. Table 2 presents an analysis of the PVM-neutralizing activities of 324 individuals grouped by age. Childen of 6 months to 1 year exhibited high and low titres in equal proportion, whereas children 1 to 2 years of age had predominantly low titres. The proportion of individuals with high titres then increased rapidly so that the sera of the majority of children possessed high PVM-neutralizing activity by 3 to 4 years of age. Thereafter, the proportion of high anti-PVM titres fluctuated somewhat, but the proportion of sera with moderate to high activities was close to the level observed in adults. The figures for the over-15 age group include the data tabulated in Table 1 . The data in Tables 1 and 2 are consistent with a hypothesis of waning maternal immunity and exposure to infection early in life.
Prevalence of PVM-neutralizing activity according to age
Seroconversion
In order to establish whether PVM-neutralizing activity was associated with respiratory infection, a collection of 108 paired serum samples from patients with upper respiratory tract infections (URTI), atypical pneumonia or bronchitis of unknown aetiology was screened for anti-PVM activity. One-hundred and four of the paired samples showed no seroconversion, the majority of the titres being in the high range (Table 3 ). The four samples listed in Table 4 exhibited significant seroconversions (i.e. more than fourfold difference between acute and convalescent sera). These results suggest that a virus similar to PVM may be responsible for 3 to 4~ of otherwise unaccounted-for respiratory infections.
The data in Tables 1 to 4 together suggest frequent exposure of the general population to PVM or a PVM-like agent. DISCUSSION RS virus and PVM, although classified on morphological grounds as the sole members of the genus Pneumovirus, nevertheless exhibit significant differences. In particular, several additional low molecular weight proteins are associated with PVM (Cash et al., 1979) . The recent molecular cloning and subsequent determination of the genetic organization of RS virus (Collins et al., 1984; Huang et al., 1985) suggest now that these morphologically similar viruses Non-structural XI 14 ?
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10 Non-structural XII 12 Non-structural * Data from Collins et al. (1984) , Huang et al. (1985) and Pringle et al. (1981) . t Data from Cash et al. (1979) . (Berthiaume et al., 1974) are more closely related than previously supposed. Table 5 illustrates that the 12 PVM-specified polypeptides can be correlated with the 12 primary or secondary products of the RS virus genome. Furthermore, the results presented here indicate that PVM, or an antigenically related virus, is able to infect man. Exposure to infection appears to be frequent and widespread, since moderate or high levels of anti-PVM activity were present in the majority of serum samples from differently constituted groups in the west of Scotland and in Oxfordshire. A similar incidence of high PVM-neutralizing titres has been found in the sera of blood donors in Nigeria (C. U. Iroegbu & C. R. Pringle, unpublished data) suggesting that PVM like RS virus is ubiquitous. As in the case of RS virus, first exposure to virus appears to occur early in life with the majority of children possessing moderate or high levels of PVM-neutralizing activity by their 3rd birthday. However, unlike RS virus where antibody is universal in adults, a small proportion (8~) of individuals in the 15 and over age group had low or no anti-PVM activity in their sera.
These results confirm the original observations of Horsfall & Hahn (1940) and Horsfall & Curnen (1946) who found evidence of antibody in man as well as in mice and a variety of other animals. Thirty-three ~o and 27 ~o of human sera respectively were found to be positive in these two surveys. Due to the sporadic occurrence of PVM in mouse colonies it was suggested that the virus might have originated in mice from human contact. The absence of any record of isolation of PVM from man during the intervening 40 years since its first isolation is surprising in view of the seroepidemiological data presented here which suggest its apparent ubiquity at the present time. However, the slow growth of the virus in cultured cells and its instability may partly explain this. It is possible also that the presence of antibodies in the animal sera used in culture media has prevented isolation of this virus.
The evidence for association with human disease is not strong; the four instances of seroconversion among 108 respiratory infections of undetermined aetiology could have been fortuitous. However, it is possible that PVM does contribute to the load of human respiratory disease. Seroconversions in two renal transplant patients have also been observed in addition to the results reported here, perhaps emphasizing the prevalence of the virus rather than its disease-producing potential. Both of these patients were experiencing a respiratory tract infection during the sampling period; however, a simultaneous rise in RS virus-neutralizing activity was also observed in one patient during the same period.
The apparent association of PVM with Paget's disease of bone is difficult to evaluate, part!cularly as the bimodal distribution observed at the start of the investigation (Fig. 2) was not typical of the wider population. The patients with Paget's disease of bone were predominantly elderly and female reflecting the normal sex distribution late in life. Age-and sex-matching within this group, however, did not affect the result. The number of cases studied is not sufficient to examine whether this introduced any bias to the result obtained. The matter is under further investigation and attempts are also being made to detect PVM antigens in Pagetic lesions and normal bone tissue. Evidence associating the other pneumovirus, RS virus, with Paget's disease of bone (Mills et al., 1981 (Mills et al., , 1982 (Mills et al., , 1984 Singer & Mills, 1983 ) has yet to be confirmed independently. Presumptive epidemiological evidence for an association between canine distemper virus and Paget's disease of bone has also been described recently (O'Driscoll & Anderson, 1985) . Despite the reports of the sporadic occurrence of other paramyxovirus (measles virus, PI3 virus, SV5) antigens in Pagetic lesions (Rebel et al., 1977 (Rebel et al., , 1980 Basl~ et al., 1979 Basl~ et al., , 1985 , the role of paramyxoviruses in Paget's disease of bone remains obscure.
